Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

Authors:

Abstract
Background: Women with multiple sclerosis (MS) are advised to discontinue interferon-beta therapy before trying to conceive. Unplanned pregnancies occur and risks related to exposure remain unclear.

This publication has 17 references indexed in Scilit: